- Home
- WALD vs CDXS Comparison
WALD vs CDXS Comparison
Compare WALD & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WALD
- CDXS
- Stock Information
- Founded
- WALD 1988
- CDXS 2002
- Country
- WALD United Kingdom
- CDXS United States
- Employees
- WALD N/A
- CDXS N/A
- Industry
- WALD Package Goods/Cosmetics
- CDXS Major Chemicals
- Sector
- WALD Consumer Discretionary
- CDXS Industrials
- Exchange
- WALD Nasdaq
- CDXS Nasdaq
- Market Cap
- WALD 404.2M
- CDXS 332.0M
- IPO Year
- WALD 2021
- CDXS 2010
- Fundamental
- Price
- WALD $3.65
- CDXS $5.28
- Analyst Decision
- WALD Strong Buy
- CDXS Buy
- Analyst Count
- WALD 4
- CDXS 2
- Target Price
- WALD $5.95
- CDXS $11.00
- AVG Volume (30 Days)
- WALD 129.3K
- CDXS 875.4K
- Earning Date
- WALD 08-27-2024
- CDXS 10-31-2024
- Dividend Yield
- WALD N/A
- CDXS N/A
- EPS Growth
- WALD N/A
- CDXS N/A
- EPS
- WALD N/A
- CDXS N/A
- Revenue
- WALD $240,382,000.00
- CDXS $64,446,000.00
- Revenue This Year
- WALD $27.44
- CDXS N/A
- Revenue Next Year
- WALD $19.55
- CDXS $2.02
- P/E Ratio
- WALD N/A
- CDXS N/A
- Revenue Growth
- WALD N/A
- CDXS N/A
- 52 Week Low
- WALD $2.41
- CDXS $2.53
- 52 Week High
- WALD $11.72
- CDXS $6.08
- Technical
- Relative Strength Index (RSI)
- WALD 54.59
- CDXS 59.97
- Support Level
- WALD $3.50
- CDXS $5.42
- Resistance Level
- WALD $4.18
- CDXS $6.01
- Average True Range (ATR)
- WALD 0.23
- CDXS 0.39
- MACD
- WALD 0.03
- CDXS -0.05
- Stochastic Oscillator
- WALD 51.15
- CDXS 46.67
About WALD Waldencast plc
Waldencast PLC is a beauty and wellness operating platform by developing, acquiring, accelerating, and scaling the next generation of conscious, purpose-driven brands. It is organized into two reportable segments namely Obagi Skincare and Milk Makeup.
About CDXS Codexis Inc.
Codexis Inc is involved in the business of providing enzyme optimization services, commercialization of proteins, and developing biocatalyst products, leveraging its proprietary CodeEvolver directed evolution technology platform. The firm's products and services include Biocatalysts and Enzymes. The company generates majority of its revenue through product sales and also licenses its technology platform CodeEvolver to pharmaceutical companies enabling them to use this technology, in-house, to engineer enzymes for their own businesses. Geographically, it derives revenue from the United States, Ireland, Switzerland, China and other markets.